Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

The Cdx-2 polymorphism in the VDR gene is associated with increased risk of cancer: a meta-analysis.

Huang J, Huang J, Ma Y, Wang H, Yang J, Xiong T, Du L.

Mol Biol Rep. 2013 Jul;40(7):4219-25. doi: 10.1007/s11033-013-2503-9. Epub 2013 May 7.

PMID:
23649760
2.

Association between vitamin D receptor gene Cdx2 polymorphism and breast cancer susceptibility.

Zhou ZC, Wang J, Cai ZH, Zhang QH, Cai ZX, Wu JH.

Tumour Biol. 2013 Dec;34(6):3437-41. doi: 10.1007/s13277-013-0919-4. Epub 2013 Jul 3.

PMID:
23821301
3.

Vitamin D receptor Cdx-2 polymorphism and premenopausal breast cancer risk in southern Pakistani patients.

Iqbal Mu, Khan TA, Maqbool SA.

PLoS One. 2015 Mar 23;10(3):e0122657. doi: 10.1371/journal.pone.0122657. eCollection 2015.

4.

Vitamin D receptor gene ApaI polymorphism and breast cancer susceptibility: a meta-analysis.

Luo S, Guo L, Li Y, Wang S.

Tumour Biol. 2014 Jan;35(1):785-90. doi: 10.1007/s13277-013-1107-2. Epub 2013 Sep 19. Retraction in: Tumour Biol. 2017 Apr 20;:.

PMID:
24048755
5.

The polymorphism in the caudal-related homeodomain protein Cdx-2 binding element in the human vitamin D receptor gene.

Arai H, Miyamoto KI, Yoshida M, Yamamoto H, Taketani Y, Morita K, Kubota M, Yoshida S, Ikeda M, Watabe F, Kanemasa Y, Takeda E.

J Bone Miner Res. 2001 Jul;16(7):1256-64.

6.

Association of vitamin D receptor gene variants, adiposity and colon cancer.

Ochs-Balcom HM, Cicek MS, Thompson CL, Tucker TC, Elston RC, J Plummer S, Casey G, Li L.

Carcinogenesis. 2008 Sep;29(9):1788-93. doi: 10.1093/carcin/bgn166. Epub 2008 Jul 14.

7.

The association between the poly(A) polymorphism in the VDR gene and cancer risk: a meta-analysis.

Huang J, Yang J, Wang H, Xiong T, Zhang H, Ma Y, Wang X, Huang J, Du L.

Tumour Biol. 2013 Jun;34(3):1833-8. doi: 10.1007/s13277-013-0724-0. Epub 2013 Mar 22.

PMID:
23519839
8.

The -1082G/A polymorphism in IL-10 gene is associated with risk of Alzheimer's disease: a meta-analysis.

Zhang Y, Zhang J, Tian C, Xiao Y, Li X, He C, Huang J, Fan H.

J Neurol Sci. 2011 Apr 15;303(1-2):133-8. doi: 10.1016/j.jns.2010.12.005. Epub 2011 Jan 20. Review.

PMID:
21255795
9.

Cdx-2 polymorphism in the promoter region of the human vitamin D receptor gene determines susceptibility to fracture in the elderly.

Fang Y, van Meurs JB, Bergink AP, Hofman A, van Duijn CM, van Leeuwen JP, Pols HA, Uitterlinden AG.

J Bone Miner Res. 2003 Sep;18(9):1632-41.

10.

Association between vitamin D receptor poly(A) polymorphism and breast cancer risk: a meta-analysis.

Xu J, Li H, Gu L, Zhou X.

Tumour Biol. 2014 Jan;35(1):589-93. doi: 10.1007/s13277-013-1082-7. Epub 2013 Sep 15.

PMID:
24037913
11.

Role of vitamin D receptor gene Cdx2 and Apa1 polymorphisms in prostate cancer susceptibility: a meta-analysis.

Wang K, Wu G, Li J, Song W.

BMC Cancer. 2016 Aug 23;16(1):674. doi: 10.1186/s12885-016-2722-2.

12.

TaqI polymorphism of VDR gene contributes to breast cancer risk.

Wang H, Wang W, Yang D, Wang S.

Tumour Biol. 2014 Jan;35(1):93-102. doi: 10.1007/s13277-013-1011-9. Epub 2013 Aug 1.

PMID:
23904261
13.

Meta-analysis on vitamin D receptor and cancer risk: focus on the role of TaqI, ApaI, and Cdx2 polymorphisms.

Serrano D, Gnagnarella P, Raimondi S, Gandini S.

Eur J Cancer Prev. 2016 Jan;25(1):85-96. doi: 10.1097/CEJ.0000000000000132.

14.

Association of Vitamin D Receptor Cdx-2 Polymorphism With Cancer Risk: A Meta-Analysis.

Dai ZM, Fei YL, Zhang WG, Liu J, Cao XM, Qu QM, Li YC, Lin S, Wang M, Dai ZJ.

Medicine (Baltimore). 2015 Aug;94(33):e1370. doi: 10.1097/MD.0000000000001370.

15.

Vitamin D Receptor ApaI (rs7975232) Polymorphism Confers Decreased Risk of Pulmonary Tuberculosis in Overall and African Population, but not in Asians: Evidence from a Meta-analysis.

Areeshi MY, Mandal RK, Wahid M, Dar SA, Jawed A, Lohani M, Abdallah AMA, Khan S, Panda AK, Mishra BN, Haque S.

Ann Clin Lab Sci. 2017 Sep;47(5):628-637.

PMID:
29066494
16.

Association between HSD17B1 rs605059 polymorphisms and the risk of uterine diseases: a systemic review and meta-analysis.

Mu X, Du X, Yao K, Zhao J, Bian C, Wang Q, Ma H, Yi T, Wu Y, Zhao X.

Int J Clin Exp Pathol. 2015 Jun 1;8(6):6012-8. eCollection 2015. Review.

17.

Association between the HSPA1B ±1267A/G polymorphism and cancer risk: a meta-analysis of 14 case-control studies.

Kuang D, Chen W, Song YZ, Yu YY, Zhang DY, Wu L, Tang J.

Asian Pac J Cancer Prev. 2014;15(16):6855-61.

18.

Vitamin D receptor BsmІ polymorphism and ovarian cancer risk: a meta-analysis.

Qin X, Lu Y, Qin A, Chen Z, Peng Q, Deng Y, Xie L, Wang J, Li R, Zeng J, Li S, Zhao J.

Int J Gynecol Cancer. 2013 Sep;23(7):1178-83. doi: 10.1097/IGC.0b013e31829db839.

PMID:
23873178
19.

Polymorphisms in the vitamin D Receptor (VDR) and the risk of ovarian cancer: a meta-analysis.

Liu Y, Li C, Chen P, Li X, Li M, Guo H, Li J, Chu R, Wang H.

PLoS One. 2013 Jun 24;8(6):e66716. doi: 10.1371/journal.pone.0066716. Print 2013.

20.

Vitamin D receptor gene polymorphisms and the risk for female reproductive cancers: A meta-analysis.

Mun MJ, Kim TH, Hwang JY, Jang WC.

Maturitas. 2015 Jun;81(2):256-65. doi: 10.1016/j.maturitas.2015.03.010. Epub 2015 Mar 21.

PMID:
25882760

Supplemental Content

Support Center